A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...
News Medical on MSN9d
Genomic insights and new treatment paradigms related to HER2-low breast cancerA new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback